Seokhwan Hyeon
0000-0001-7909-326X
1 paper found
Refreshing results…
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023
Missing publications? Search for publications with a matching author name.